Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal ...

Pfizer (PFE) stock gains as Braftovi combo shows survival benefits in a late-stage trial for metastatic colorectal cancer ...

Previous research connected a 10% increase in ultra-processed food consumption with a 16% increase in breast cancer deaths ...

Learn the causes, symptoms, and treatment strategies for pseudomembranous colitis, a serious colon inflammation often triggered by antibiotics.

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer ...

National Comprehensive Cancer Network® (NCCN®) Guidelines for colon and rectal cancer were updated to include ctDNA as a prognostic marker and high risk factor for recurrence NCCN guideline for merkel ...

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

The bacteria have appendages called pili, with molecules known as adhesins on the end, which can attach to receptors on intestinal epithelial cells. Pili binding was shown to increase the ...

Additionally, transcriptomic analysis was performed to examine the expression of tumor-related genes in the epithelial and immune cells of the colon. The infected mice also showed higher levels of ...

Colon cancer ranks as the third most prevalent ... allows bacteria to produce the genotoxin colibactin nearby epithelial cells, which leads to DNA damage and cancer development." ...

In this study, the authors describe the participation of the Hes4-BEST4-Twist axis in controlling the process of epithelial ... advancement of colorectal cancers (CRC). They assert that this axis ...

Epithelial cells are packed tightly together and serve ... Most breast cancers Almost all prostate cancers 95% of pancreatic cancers 96% of colorectal cancers 40% of non-small-cell lung cancers ...